Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cybin | CYBN | Nov 19, 2024 | 11.00 | +3.77 |
Cyclacel Pharmaceuticals | CYCC | Nov 19, 2024 | 0.37 | +3.38 |
Cyclacel Pharmaceuticals Pref | CYCCP | Nov 19, 2024 | 6.94 | +4.99 |
Cyclerion Therapeutics | CYCN | Nov 19, 2024 | 1.76 | -15.79 |
Cyclo Therapeutics | CYTH | Nov 19, 2024 | 0.68 | -5.42 |
Cyngn | CYN | Nov 19, 2024 | 6.19 | +7.47 |
Cytek Biosciences | CTKB | Nov 19, 2024 | 6.13 | +1.66 |
Cytokinetics | CYTK | Nov 19, 2024 | 51.09 | -1.64 |
Cytomed Therapeutics | GDTC | Nov 19, 2024 | 2.01 | +3.58 |
CytomX Therapeutics | CTMX | Nov 19, 2024 | 0.89 | +3.42 |
Cytosorbents | CTSO | Nov 19, 2024 | 0.96 | +3.17 |
D-MARKET Electronic Services & Trading ADR | HEPS | Nov 19, 2024 | 2.85 | -1.38 |
D-Wave Quantum | QBTS | Nov 19, 2024 | 1.49 | +3.47 |
D.R. Horton | DHI | Nov 19, 2024 | 162.30 | +0.53 |
Dada Nexus ADR | DADA | Nov 19, 2024 | 1.39 | -3.47 |
Daily Journal | DJCO | Nov 19, 2024 | 543.11 | -2.05 |
Dakota Gold | DC | Nov 19, 2024 | 2.22 | +2.30 |
Daktronics | DAKT | Nov 19, 2024 | 15.18 | +2.53 |
DallasNews A | DALN | Nov 19, 2024 | 6.11 | +21.23 |
Dana | DAN | Nov 19, 2024 | 7.87 | -1.50 |
Danaher | DHR | Nov 19, 2024 | 230.84 | +0.34 |
Danaos | DAC | Nov 19, 2024 | 86.33 | -0.07 |
Danimer Scientific | DNMR | Nov 19, 2024 | 6.13 | -23.76 |
DAQO New Energy ADR | DQ | Nov 19, 2024 | 18.32 | -3.78 |
Darden Restaurants | DRI | Nov 19, 2024 | 160.85 | -2.19 |
Daré Bioscience | DARE | Nov 19, 2024 | 3.18 | -0.63 |
DarioHealth | DRIO | Nov 19, 2024 | 0.79 | -1.25 |
Darling Ingredients | DAR | Nov 19, 2024 | 41.80 | -1.62 |
Data I/O | DAIO | Nov 19, 2024 | 2.57 | 0.00 |
Data Storage | DTST | Nov 19, 2024 | 4.03 | +7.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.